As reported in Fig. 3, BCL-XL overexpressing clones from both melanoma (Fig. 3a) and glioblastoma (Fig. 3d), demonstrated an enhanced VM, evaluated in terms of both tube length and number of intersections, when compared to the respective corresponding control clones. Here, BCL2L1 is linked to glioblastoma.